Saccharomyces boulardii CNCM I-745 vs Biocodex Florastor
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Available axes
Side-by-side release fields
Each side retains its own unit and denominator. Entity evidence and containing-label observations do not imply a product score or a head-to-head efficacy finding.
A2: entity evidence is shown separately. Evidence amount: 1.00; PubMed RCT records: 12; direction balance: The direction of the study results has not been extracted.
Axis 3 · measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4 · observed review panel
29 observed documents or mentions; service share Not available in this release.; outcome-bearing share Not available in this release.; burst signal Not available in this release..
Preference-dependent summary and price
GIS: no aggregate entity score. Price: undefined: no observation in this release. Observed: undefined: observation date unavailable.
Forms: Capsule: 1 · Powder: 1, across the 2 published products whose label states a form.
A1: 75.00. Identity: A deposit or other confirmed identifier is available.; quantity disclosure: 100.0%; potency: The potency basis is not stated..
Axis 2 · evidence
A2: 100.00. Evidence amount: 1.00; PubMed RCT records: 12; direction balance: The direction of the study results has not been extracted.
Axis 3 · measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4 · observed review panel
0 observed documents or mentions; service share Not available in this release.; outcome-bearing share Not available in this release.; burst signal Not available in this release..
Preference-dependent summary and price
GIS: 88.75. Price: undefined: no observation in this release. no verified match (DataForSEO, 2026-09-20) Observed: 2026-09-20.
Saccharomyces boulardii CNCM I-745 prints strain designations for 0 of 3 observed organisms (0.0%), compared with 0 of 1 (0.0%) for Biocodex Florastor. Window: NIH DSLD snapshot Sep 2026.
Saccharomyces boulardii CNCM I-745 states through_expiry on 0 of 3 observed labels (0.0%), compared with 0 of 2 (0.0%) for Biocodex Florastor. Window: NIH DSLD snapshot Sep 2026.
Saccharomyces boulardii CNCM I-745: 12 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 12 records (retracted records excluded; 0 retracted records match the query separately). Biocodex Florastor: 12 PubMed record matches across 1 printed-entity queries (query dates: 2026-09-15). Records may overlap across these ingredient queries; this is not a product trial count.
12 / Not available in this release. PubMed records in the union of both compared entries · NIH DSLD snapshot Sep 2026 · comparison.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
0 of 2 compared entries have a numeric price: Saccharomyces boulardii CNCM I-745, No numeric price observation is available in this release.; Biocodex Florastor, No verified price match is available.. Window: NIH DSLD snapshot Sep 2026.